MTM Patient Assessment & Care Planning 4 — Questions and Answers
Question 1: A pharmacist is assessing a patient with heart failure who is taking an NSAID for arthritis pain. What is the primary concern in the care planning process?
- NSAIDs reduce the efficacy of ACE inhibitors and promote sodium retention, worsening heart failure (Correct answer)
- NSAIDs cause hyperkalemia that directly damages myocardial cells
- NSAIDs are converted to toxic metabolites in heart failure patients
- NSAIDs are contraindicated only in patients with ejection fraction above 60%
Correct answer: NSAIDs reduce the efficacy of ACE inhibitors and promote sodium retention, worsening heart failure
NSAIDs antagonize the effects of ACE inhibitors/diuretics and promote fluid retention, exacerbating heart failure symptoms.
Question 2: When prioritizing drug therapy problems in a care plan, which factor should be given the highest weight?
- Cost of resolving the problem
- Severity and immediacy of harm to the patient (Correct answer)
- Number of medications involved
- Patient's personal preference for keeping current medications unchanged
Correct answer: Severity and immediacy of harm to the patient
Drug therapy problems should be prioritized based on the potential severity of harm and how urgently intervention is needed.
Question 3: Which of the following is an example of a SMART goal in an MTM care plan?
- Patient will feel better
- Patient will reduce blood pressure
- Patient will achieve systolic BP below 130 mmHg within 4 weeks (Correct answer)
- Patient should take medications more consistently
Correct answer: Patient will achieve systolic BP below 130 mmHg within 4 weeks
SMART goals are Specific, Measurable, Achievable, Relevant, and Time-bound; a target BP with a defined timeframe meets all criteria.
Question 4: A pharmacist discovers a patient is taking two different statins simultaneously (atorvastatin and rosuvastatin prescribed by two different providers). Which drug therapy problem category applies?
- Dosage too high
- Unnecessary drug therapy — duplicate therapy (Correct answer)
- Needs additional drug therapy
- Wrong drug
Correct answer: Unnecessary drug therapy — duplicate therapy
Duplicate therapy occurs when two drugs from the same class are prescribed concurrently without clinical rationale, constituting unnecessary therapy.
Question 5: During a patient assessment, the pharmacist notes the patient has difficulty opening child-proof caps. How should this be addressed in the care plan?
- Discontinue medications that come in child-proof containers
- Document as a barrier to adherence and recommend easy-open caps or blister packs (Correct answer)
- Ignore the issue as it is not a clinical concern
- Transfer care to a home health nurse immediately
Correct answer: Document as a barrier to adherence and recommend easy-open caps or blister packs
Physical barriers to adherence such as difficulty opening containers should be documented and addressed with practical solutions like easy-open caps.
Question 6: A patient with atrial fibrillation and a CHA₂DS₂-VASc score of 4 is not on anticoagulation. Which drug therapy problem does this represent?
- Adverse drug reaction
- Dosage too low
- Needs additional drug therapy (Correct answer)
- Unnecessary drug therapy
Correct answer: Needs additional drug therapy
A CHA₂DS₂-VASc score of 4 indicates high stroke risk, and the absence of anticoagulation represents a need for additional drug therapy.
Question 7: Which statement best describes the pharmacist's role in collaborative care planning for MTM patients?
- The pharmacist independently prescribes new therapies without consulting the care team
- The pharmacist identifies drug therapy problems and communicates recommendations to prescribers while engaging patients in self-management (Correct answer)
- The pharmacist only performs dispensing functions and defers all clinical judgments
- The pharmacist replaces the physician as the primary care provider
Correct answer: The pharmacist identifies drug therapy problems and communicates recommendations to prescribers while engaging patients in self-management
MTM pharmacists identify and resolve drug therapy problems through collaboration with prescribers and patient education, not independent prescribing.
MTM Patient Assessment & Care Planning 4
A pharmacist is assessing a patient with heart failure who is taking an NSAID for arthritis pain.
What is the primary concern in the care planning process?